Kiniksa Pharmaceuticals International KNSA
NASDAQ KNSA
$75.79 +0.57 (+0.76%)
At close: Oct 2, 2026 · 4:00 PM EDT

Kiniksa Pharmaceuticals International (KNSA) Depreciation and Depletion (2017 - 2026)

Updated

Kiniksa Pharmaceuticals International's Depreciation and Depletion was $165,000 in Q2 2026, compared with $13,000 a year earlier and up 14.6% from the prior quarter.

Analysis

Kiniksa Pharmaceuticals International (KNSA) Depreciation and Depletion (2017 - 2026) Analysis & Trends

On a trailing twelve-month basis, Kiniksa Pharmaceuticals International's Depreciation and Depletion was $457,000 through Jun 30, 2026, up 104.9% year-over-year; for FY2025, it came in at $196,000, down 56.3% from FY2024.

  • Depreciation and Depletion has now declined for five consecutive years, with a five-year compound annual growth rate of -39.4% (FY2020 to FY2025).
  • In earlier years, Depreciation and Depletion was $448,000 in FY2024 (-59.6%), $1.11 million in FY2023 (-5.9%), $1.18 million in FY2022 (-19.0%) and $1.46 million in FY2021 (-39.5%).
  • The Q2 2026 figure marks the highest quarterly Depreciation and Depletion since Q4 2023.
  • Compared with a year earlier, Depreciation and Depletion was higher in two of the last seven quarters, with an average decline of 2.8%.
  • The best year-over-year quarter for Depreciation and Depletion over five years was Q1 2026 (growth of 311.4%); the worst was Q2 2025 (a decline of 89.1%).
  • Per Business Quant data, KNSA's Depreciation and Depletion in the three quarters before Q2 2026 was $144,000 (Q1 2026), $121,000 (Q4 2025) and $27,000 (Q3 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Dep. & Depletion (Qtr)
1 Eli Lilly 1,076.25 Bn 1,044.84 Bn 19.71 Bn -
2 Johnson & Johnson 617.18 Bn 535.70 Bn 17.26 Bn -
3 AbbVie 464.58 Bn 437.73 Bn 12.70 Bn 194.00 Mn
4 Merck 356.04 Bn 310.47 Bn 12.21 Bn 599.00 Mn
5 Novartis Ag 269.07 Bn 224.94 Bn 11.24 Bn -
6 Astrazeneca 243.21 Bn 216.77 Bn 12.86 Bn -
7 Amgen 217.88 Bn 173.28 Bn 7.24 Bn -
8 Gilead Sciences 179.62 Bn 153.74 Bn 6.22 Bn 98.00 Mn
9 Pfizer 158.45 Bn 105.40 Bn 10.94 Bn -
10 Kiniksa Pharmaceuticals International 11.82 Bn 10.56 Bn 220.03 Mn 165,000.00
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 165,000.00
Mar 31, 2026 144,000.00
Dec 31, 2025 121,000.00
Sep 30, 2025 27,000.00
Jun 30, 2025 13,000.00
Mar 31, 2025 35,000.00
Dec 31, 2024 88,000.00
Sep 30, 2024 87,000.00
Jun 30, 2024 119,000.00
Mar 31, 2024 154,000.00
Dec 31, 2023 236,000.00
Sep 30, 2023 292,000.00
Jun 30, 2023 292,000.00
Mar 31, 2023 289,000.00
Dec 31, 2022 294,000.00
Sep 30, 2022 177,000.00
Jun 30, 2022 350,000.00
Mar 31, 2022 359,000.00
Dec 31, 2021 376,000.00
Sep 30, 2021 373,000.00
API Access

Kiniksa Pharmaceuticals International Depreciation and Depletion API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=depreciation-and-depletion&ticker=KNSA&period=max&api_key=YOUR_API_KEY